REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
01/26/2026
Back to search
Official data from USPTO
JUST IN TIME GCP
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: US
Quick snapshot
JUST IN TIME GCP
ST13
US500000088802445Class
35, 41, 42, 45
Filing
88802445
Registration
6254934
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
19
Latest update
01/27/2026
Classification
Registered
Trademark type
Word
Nice classes
35, 41, 42, 45
Filing date
02/19/2020
Registration date
01/26/2021
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
01/26/2021
Last transaction
01/27/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
First use anywhere
03/24/2010
First use in commerce
03/24/2010
Drawing code
4
Owner type
03
Owner location
Warrington, PA
Examiner
IM, JEAN H
Law office
L10
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
DWD & Associates, Inc.
Representatives
Christopher D. Olszyk, Jr. FOX ROTHSCHILD LLP
Technical classification
Nice Classes
Class 35Class 41Class 42Class 45
Vienna Codes
No Vienna codes available.
Goods and services
Class 35
Business consulting and process assessment services in the nature of providing information management services in the field of document management in clinical research trials and clinical trial result submission; Business consulting in the field of clinical research trials; Clinical research compliance consultingtracking and assessing clinical research regulatory compliance for business purposes; Business consulting and management in the field of clinical trialsclinical data and regulatory submission management on behalf of pharmaceuticalbiopharmaceuticalbiotechnology and medical device companies to assist in clinical researchclinical trials and applications for drug approval; Providing independent review of clinical trials for business purposes; Data-processing and creation and management of documentsservices comprising the review and analysis of business information comprised of written communications and information in documents and management of business records in the nature of documentsfor use in connection with clinical trial master files in relation to good clinical practicesall for business purposes
Class 41
Educational servicesclassesworkshopsseminars and training programs in the field of clinical trial quality management systemsclinical trial auditinggood clinical practice standards and procedures
Class 42
Quality management servicesquality evaluation and analysisquality assurancequality controlin the fields of pharmaceuticalbiopharmaceuticalbiotechnology and medical device clinical research and testing; Quality audit services in the nature of evaluation and analysisquality assurance consultancy in the field of clinical trial and clinical research quality control for others; Technical inspection servicesinspection of clinical dataclinical procedureclinical processclinical databaseclinical reports for othersfor quality control purposes; Preparation of reports in relation to clinical trials and clinical research and preparation of reports on management of scientific research projectsclinical research projectsclinical trialsclinical trial auditspharmaceutical product evaluationsdrug development and pharmaceutical product evaluationsall of the foregoing for quality control purposes
Class 45
Consulting in the field of governmental regulatory compliance inspection preparednessregulatory compliance assessment and auditing services in the pharmaceuticalbiopharmaceuticalbiotechnology and medical device fieldfor regulatory compliance purposes; Consulting services in the field of pharmaceuticalbiopharmaceuticalbiotechnology and medical device clinical trial regulatory compliance in the fields of creating case report forms for clinical trialsgenerating compliance and performance reportsmanaging clinical datamonitoring and tracking clinical trial audit activitiesreviewing and auditing clinical trial dataaccessing clinical trial standard setting resourcesall for regulatory compliance purposes
Publications
History of USPTO decisions and trademark events.
19 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
01/26/2021
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
11/10/2020
PUBO
PUBLISHED FOR OPPOSITION
11/10/2020
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
10/21/2020
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
10/07/2020
XAEC
EXAMINER'S AMENDMENT ENTERED
10/07/2020
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
10/07/2020
GNEA
EXAMINERS AMENDMENT E-MAILED
10/07/2020
CNEA
EXAMINERS AMENDMENT -WRITTEN
10/07/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
09/16/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
09/16/2020
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
09/16/2020
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
05/15/2020
GNRT
NON-FINAL ACTION E-MAILED
05/15/2020
CNRT
NON-FINAL ACTION WRITTEN
05/15/2020
DOCK
ASSIGNED TO EXAMINER
05/08/2020
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
02/24/2020
NWAP
NEW APPLICATION ENTERED
02/22/2020
Continuous trademark protection
Get notified about every new filing that threatens JUST IN TIME GCP or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.